News & events

The recording of our webinar, ‘Understanding Severe Asthma’, which took place on 18 June 2025, is available below. If you

The recording of our webinar, ‘Asthma & Exercise: Raising Awareness in the GAA Community’, which took place on 28 May,

We are calling on people living with asthma – and the healthcare professionals who support them – to take part

Asthma is one of the most common chronic conditions affecting 1 in 5 people at some stage of their lives.

To mark Asthma Awareness Week, we are calling on people across the country to reclaim their health and confidence through

The recording of our ‘Exercise & Asthma’ webinar, which took place on 2 April 2025 is now available below. This

Poorly controlled asthma can have a big impact on a child’s health, as well as their ability to play and learn. Uncontrolled asthma causes children to miss school, can lead to hospitalisation, and, although it is rare, in a small number of cases children can die from asthma.

The Asthma Society of Ireland is the national representative body for people with asthma in Ireland, advocating for the approximately 450,000 people living with the condition. As a not-for-profit organisation operating for over 50 years, our mission is to ensure that everyone with asthma in Ireland can live a full life, symptom-free.

A new way to treat asthma and COPD flare-ups could be a "game-changer," researchers say. A new study, published in The Lancet today, has investigated the use of high-tech biologic therapy Benralizumab (Fasenra) in treating acute asthma exacerbations. Benralizumab (Fasenra) works by targeting white blood cells that cause inflammation. Already used in regular low doses to treat severe asthma, researchers have now tested its efficacy in tackling asthma attacks using a single high-dose injection. Early studies suggest this new use of the drug cuts the need for further treatment by 30%.